The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Transforming Growth Factor β1 Induces Hypoxia-inducible Factor-1 Stabilization through Selective Inhibition of PHD2 Expression
Open accessAbstract
The hypoxia-inducible transcription factor-1 (HIF-1) is central to a number of pathological processes through the induction of specific genes such as vascular endothelial growth factor (VEGF). Even though HIF-1 is highly regulated by cellular oxygen levels, other elements of the inflammatory and tumor microenvironment were shown to influence its activity under normal oxygen concentration. Among others, recent studies indicated that transforming growth factor (TGF) beta increases the expression of the regulatory HIF-1alpha subunit, and induces HIF-1 DNA binding activity. Here, we demonstrate that TGFbeta acts on HIF-1alpha accumulation and activity by increasing HIF-1alpha protein stability. In particular, we demonstrate that TGFbeta markedly and specifically decreases both mRNA and protein levels of a HIF-1alpha-associated prolyl hydroxylase (PHD), PHD2, through the Smad signaling pathway. As a consequence, the degradation of HIF-1alpha was inhibited as determined by impaired degradation of a reporter protein containing the HIF-1alpha oxygen-dependent degradation domain encompassing the PHD-targeted prolines. Moreover, inhibition of the TGFbeta1 converting enzyme, furin, resulted in increased PHD2 expression, and decreased basal HIF-1alpha and VEGF levels, suggesting that endogenous production of bioactive TGFbeta1 efficiently regulates HIF-1-targeted genes. This was reinforced by results from HIF-1alpha knock-out or HIF-1alpha-inhibited cells that show impairment in VEGF production in response to TGFbeta. This study reveals a novel mechanism by which a growth factor controls HIF-1 stability, and thereby drives the expression of specific genes, through the regulation of PHD2 levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Tacchini, L., Ponti, C. D., Matteucci, E., Follis, R., & Desiderio, M. A. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh227 · Cited by 114
RetractedWang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Chomczyński, P. (1993) · PubMed · Cited by 2,788
Semenza, G. L., & Wang, G. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5447 · Cited by 2,617
(1999) · PubMed · Cited by 2,204
Huang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113
NEW EMBO MEMBERS REVIEW: Transcriptional control by the TGF-beta/Smad signaling system
Massague, J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.8.1745 · Cited by 1,966
Salceda, S., & Caro, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22642 · Cited by 1,674
TGFβ signals through a heteromeric protein kinase receptor complex
Wrana, J. L., Attisano, L., Cárcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X.-F., & Massague, J. (1992) · Cell · doi:10.1016/0092-8674(92)90395-s · Cited by 1,526
Tian, H., McKnight, S. L., & Russell, D. W. (1997) · Genes & Development · doi:10.1101/gad.11.1.72 · Cited by 1,351
Berra, E., Benizri, E., Ginouvès, A., Volmat, V., Roux, D., & Pouysségur, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg392 · Cited by 1,348
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.
Ravi, R. K., Mookerjee, B., Bhujwalla, Z. M., Sutter, T. R., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A. (2000) · PubMed · Cited by 1,230
Maxwell, P. H., Dachs, G. U., Gleadle, J. M., Nicholls, L. G., Harris, A. L., Stratford, I. J., Hankinson, O., Pugh, C. W., & Ratcliffe, P. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8104 · Cited by 1,084
Masson, N., Willam, C., Maxwell, P. H., Pugh, C. W., & Ratcliffe, P. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.18.5197 · Cited by 1,014
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
Ravi, R., Mookerjee, B., Bhujwalla, Z. M., Sutter, C. H., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A. (2000) · Genes & Development · doi:10.1101/gad.14.1.34 · Cited by 967
Fukuda, R., Hirota, K., Fan, F., Jung, Y. D., Ellis, L. M., & Semenza, G. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203781200 · Cited by 821
Wang, G., & Semenza, G. (1993) · Blood · doi:10.1182/blood.v82.12.3610.3610 · Cited by 766
Jung, Y.-J., Isaacs, J. S., Lee, S., Trepel, J., & Neckers, L. (2003) · The FASEB Journal · doi:10.1096/fj.03-0329fje · Cited by 679
Laping, N. J., Grygielko, E., Mathur, A., Butter, S., Bomberger, J., Tweed, C., Martin, W., Fornwald, J., Lehr, R., Harling, J., et al. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.58 · Cited by 635
Treins, C., Giorgetti-Peraldi, S., Murdaca, J., Semenza, G. L., & Van Obberghen, E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204152200 · Cited by 539
Suppression of tumor growth through disruption of hypoxia-inducible transcription
Kung, A. L., Wang, S., Klco, J. M., Kaelin, W. G., & Livingston, D. M. (2000) · Nature Medicine · doi:10.1038/82146 · Cited by 501
Richard, D. E., Berra, E., & Pouysségur, J. (2000) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61441-9 · Cited by 488
Self-citationYC-1: A Potential Anticancer Drug Targeting Hypoxia-Inducible Factor 1
Yeo, E.-J., Chun, Y.-S., Cho, Y.-S., Kim, J., Lee, J.-C., Kim, M.-S., & Park, J.-W. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.7.516 · Cited by 476
Interleukin-1β and Tumor Necrosis Factor- Stimulate DNA Binding of Hypoxia-Inducible Factor-1
Hellwig-Bürgel, T., Rutkowski, K., Metzen, E., Fandrey, J., & Jelkmann, W. (1999) · Blood · doi:10.1182/blood.v94.5.1561 · Cited by 475
Blouin, C. C., Pagé, E. L., Soucy, G. M., & Richard, D. E. (2004) · Blood · doi:10.1182/blood-2003-07-2427 · Cited by 458
Self-citationInduction of HIF–1α in response to hypoxia is instantaneous
Jewell, U. R., Kvietikova, I., Scheid, A., Bauer, C., Wenger, R. H., & Gassmann, M. (2001) · The FASEB Journal · doi:10.1096/fj.00-0732fje · Cited by 444
Görlach, A., Diebold, I., Schini-Kerth, V. B., Berchner-Pfannschmidt, U., Roth, U., Brandes, R. P., Kietzmann, T., & Busse, R. (2001) · Circulation Research · doi:10.1161/hh1301.092678 · Cited by 416
Nitric Oxide Impairs Normoxic Degradation of HIF-1α by Inhibition of Prolyl Hydroxylases
Metzen, E., Zhou, J., Jelkmann, W., Fandrey, J., & Brüne, B. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-12-0791 · Cited by 414
Processing of Transforming Growth Factor β1 Precursor by Human Furin Convertase
Dubois, C. M., Laprise, M.-H., Blanchette, F., Gentry, L. E., & Leduc, R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10618 · Cited by 405
Self-citationMARXSEN, J. H., STENGEL, P., DOEGE, K., HEIKKINEN, P., JOKILEHTO, T., WAGNER, T., JELKMANN, W., JAAKKOLA, P., & METZEN, E. (2004) · Biochemical Journal · doi:10.1042/bj20040620 · Cited by 386
Induction of Hypoxia-inducible Factor-1α by Transcriptional and Translational Mechanisms
Pagé, E. L., Robitaille, G. A., Pouysségur, J., & Richard, D. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209114200 · Cited by 385
Self-citationSalnikow, K., Donald, S. P., Bruick, R. K., Zhitkovich, A., Phang, J. M., & Kasprzak, K. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403057200 · Cited by 319
Mantovani, A., Allavena, P., & Sica, A. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.03.016 · Cited by 311
Jean, F., Stella, K., Thomas, L., Liu, G., Xiang, Y., Reason, A. J., & Thomas, G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7293 · Cited by 263
Blancher, C., Moore, J. W., Talks, K., Houlbrook, S., & Harris, A. L. (2000) · PubMed · Cited by 255
Evidence that Furin Is an Authentic Transforming Growth Factor-β1-Converting Enzyme
Dubois, C. M., Blanchette, F., Laprise, M.-H., Leduc, R., Grondin, F., & Seidah, N. G. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63970-3 · Cited by 247
Self-citationHasegawa, Y., Takanashi, S., Kanehira, Y., Tsushima, T., Imai, T., & Okumura, K. (2001) · Cancer · doi:10.1002/1097-0142(20010301)91:5<964::aid-cncr1086>3.0.co;2-o · Cited by 244
c-myc Is a Downstream Target of the Smad Pathway
Yagi, K., Furuhashi, M., Aoki, H., Goto, D., Kuwano, H., Sugamura, K., Miyazono, K., & Kato, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m104170200 · Cited by 244
Stoeltzing, O., McCarty, M. F., Wey, J. S., Fan, F., Liu, W., Belcheva, A., Bucana, C. D., Semenza, G. L., & Ellis, L. M. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh168 · Cited by 241
Role of transforming growth factor beta in cancer
Pasche, B. (2001) · Journal of Cellular Physiology · doi:10.1002/1097-4652(200002)186:2<153::aid-jcp1016>3.0.co;2-j · Cited by 235
Increased expression of hypoxia inducible factor-1alpha in rat and human prostate cancer.
Zhong, H., Agani, F. H., Baccala, A. A., Laughner, E., Rioseco‐Camacho, N., Wb, I., Simons, J. W., & Semenza, G. L. (1998) · PubMed · Cited by 232
Vleugel, M. M., Greijer, A. E., Shvarts, A., van der Groep, P., van Berkel, M., Aarbodem, Y., van Tinteren, H., Harris, A. L., van Diest, P. J., & van der Wall, E. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2004.019885 · Cited by 227
Kim, E.-S., Kim, M.-S., & Moon, A. (2004) · International Journal of Oncology · doi:10.3892/ijo.25.5.1375 · Cited by 219
Regulation of HIF prolyl hydroxylases by hypoxia‐inducible factors
Aprelikova, O., Chandramouli, G. V. R., Wood, M., Vasselli, J. R., Riss, J., Maranchie, J. K., Linehan, W. M., & Barrett, J. C. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20067 · Cited by 214
METZEN, E., STIEHL, D. P., DOEGE, K., MARXSEN, J. H., HELLWIG-BÜRGEL, T., & JELKMANN, W. (2005) · Biochemical Journal · doi:10.1042/bj20041736 · Cited by 208
Lu, S.-L., Reh, D., Li, A. G., Woods, J., Corless, C. L., Kulesz-Martin, M., & Wang, X.-J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1032 · Cited by 197
Mammalian EGLN genes have distinct patterns of mRNA expression and regulation
Lieb, M. E., Menzies, K., Moschella, M. C., Ni, R., & Taubman, M. B. (2002) · Biochemistry and Cell Biology · doi:10.1139/o02-115 · Cited by 186
Benckert, C., Jonas, S., Cramer, T., von Marschall, Z., Schäfer, G., Peters, M., Wagner, K., Radke, C., Wiedenmann, B., Neuhaus, P., et al. (2003) · PubMed · Cited by 185
Zhou, J., Schmid, T., & Brüne, B. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-09-0598 · Cited by 177
Snail and E47 repressors of E-cadherin induce distinct invasive and angiogenic properties in vivo
Peinado, H., Marin, F., Cubillo, E., Stark, H.-J., Fusenig, N., Nieto, M. A., & Cano, A. (2004) · Journal of Cell Science · doi:10.1242/jcs.01145 · Cited by 175
McMahon, S., Grondin, F., McDonald, P. P., Richard, D. E., & Dubois, C. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413248200 · Cited by 170
Self-citationCioffi, C. L., Qin Liu, X., Kosinski, P. A., Garay, M., & Bowen, B. R. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00453-4 · Cited by 170
Garten, W., Hallenberger, S., Ortmann, D., Schäfer, W., Vey, M., Angliker, H., Shaw, E., & Klenk, H. D. (1994) · Biochimie · doi:10.1016/0300-9084(94)90149-x · Cited by 167
Kuwai, T., Kitadai, Y., Tanaka, S., Onogawa, S., Matsutani, N., Kaio, E., Ito, M., & Chayama, K. (2003) · International Journal of Cancer · doi:10.1002/ijc.11068 · Cited by 162
TGFβ-induced downregulation of E-cadherin-based cell-cell adhesion depends on PI3-kinase and PTEN
Vogelmann, R., Nguyen-tat, M.-D., Giehl, K., Adler, G., Wedlich, D., & Menke, A. (2005) · Journal of Cell Science · doi:10.1242/jcs.02594 · Cited by 159
Pro-protein convertase gene expression in human breast cancer
Cheng, M., Watson, P. H., Paterson, J. A., Seidah, N. G., Chrétien, M., & Shiu, R. P. C. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970611)71:6<966::aid-ijc10>3.0.co;2-4 · Cited by 154
Long, J., Zuo, D., & Park, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504477200 · Cited by 151
Chun, Y.-S., Yeo, E.-J., Choi, E., Teng, C.-M., Bae, J.-M., Kim, M.-S., & Park, J.-W. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00564-0 · Cited by 151
Herrera, B. M., Murillo, M. M., Alvarez, A. M., Beltrán, J., Fernández, M., & Fabregat, I. (2003) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2003.09.020 · Cited by 139
Mbikay, M., Sirois, F., Yao, J., Seidah, N. G., & Chrétien, M. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.258 · Cited by 136
TGFbeta1 regulates gene expression of its own converting enzyme furin.
Blanchette, F., Day, R. W., Dong, W., Laprise, M., & Dubois, C. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119365 · Cited by 131
Self-citationBlanchette, F., Rivard, N., Rudd, P. A., Grondin, F., Attisano, L., & Dubois, C. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100093200 · Cited by 121
Self-citationTreins, C., Giorgetti‐Peraldi, S., Murdaca, J., Monthouel, M.-N., & OBBERGHEN, E. V. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0239 · Cited by 120
Mechanisms by which oxygen regulates gene expression and cell-cell interaction in the vasculature
Kourembanas, S., Morita, T., Liu, Y., & Christou, H. A. (1997) · Kidney International · doi:10.1038/ki.1997.58 · Cited by 119
Janssen, H. L., Haustermans, K. M., Sprong, D., Blommestijn, G. J. F., Hofland, I., Hoebers, F. J. P., Blijweert, E., Raleigh, J. A., Semenza, G. L., Varia, M. A., et al. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)03935-4 · Cited by 116
Role of AP-1 and HIF-1 Transcription Factors in TGF-β Activation of VEGF Expression
Shih, S., & Claffey, K. P. (2001) · Growth Factors · doi:10.3109/08977190109001073 · Cited by 116
Siegfried, G., Khatib, A., Benjannet, S., Chrétien, M., & Seidah, N. G. (2003) · PubMed · Cited by 106
A Unique Role of the β-2 Thyroid Hormone Receptor Isoform in Negative Regulation by Thyroid Hormone
Langlois, M., Zanger, K., Monden, T., Safer, J. D., Hollenberg, A. N., & Wondisford, F. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.24927 · Cited by 105
Javelaud, D., Delmas, V., Möller, M., Sextius, P., André, J., Ménashi, S., Larue, L., & Mauviel, A. (2005) · Oncogene · doi:10.1038/sj.onc.1208900 · Cited by 101
TGFβ-1 regulation of VEGF production by breast cancer cells
Donovan, D., Harmey, J. H., Toomey, D., Osborne, D. H., Redmond, H. P., & Bouchier‐Hayes, D. J. (1997) · Annals of Surgical Oncology · doi:10.1007/bf02303745 · Cited by 98
Breier, G., Blum, S., Peli, J., Groot, M., Wild, C., Risau, W., & Ernst Reichmann, A. (2001) · International Journal of Cancer · doi:10.1002/ijc.1599 · Cited by 96
Hypoxia-inducible factor-1alpha is an intrinsic marker for hypoxia in cervical cancer xenografts.
Vukovic, V. M., Haugland, H. K., Nicklee, T., Morrison, A. J., & Hedley, D. W. (2001) · PubMed · Cited by 90
Chua, C. C., Hamdy, R. C., & Chua, B. H. L. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(00)00040-9 · Cited by 56
Shimizu, S., Nishikawa, Y., Kuroda, K., Takagi, S., Kozaki, K., Hyuga, S., Saga, S., & Matsuyama, M. (1996) · PubMed · Cited by 51
Chiu, C., Maddock, D. A., Zhang, Q., Souza, K. P., Townsend, A. R., & Wan, Y. (2001) · International Journal of Molecular Medicine · doi:10.3892/ijmm.8.3.251 · Cited by 51
Role of Smad3 in the regulation of rat telomerase reverse transcriptase by TGFβ
Hu, B., Tack, D. C., Liu, T., Wu, Z., Ullenbruch, M. R., & Phan, S. H. (2005) · Oncogene · doi:10.1038/sj.onc.1209140 · Cited by 46
Laprise, M., Grondin, F., Cayer, P., McDonald, P. P., & Dubois, C. M. (2002) · Blood · doi:10.1182/blood.v100.10.3578 · Cited by 26
Self-citation
Cited by
Hypoxia-Inducible Factors, Stem Cells, and Cancer
Keith, B., & Simon, M. C. (2007) · Cell · doi:10.1016/j.cell.2007.04.019 · Cited by 1,179
Serrano-Gomez, S. J., Maziveyi, M., & Alahari, S. K. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0502-x · Cited by 814
The Role of Hypoxia in Development of the Mammalian Embryo
Dunwoodie, S. L. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.11.008 · Cited by 651
HIF‐1 at the crossroads of hypoxia, inflammation, and cancer
Balamurugan, K. (2016) · International Journal of Cancer · doi:10.1002/ijc.29519 · Cited by 572
Clambey, E. T., McNamee, E. N., Westrich, J. A., Glover, L. E., Campbell, E. L., Jedlicka, P., de Zoeten, E. F., Cambier, J. C., Stenmark, K. R., Colgan, S. P., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202366109 · Cited by 560
Metadata
- Authors
- McMahon, S., Charbonneau, M., Grandmont, S., Richard, D. E., & Dubois, C. M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-08
- Volume
- 281
- Issue
- 34
- Pages
- 24171-24181
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1986014993
- Cited by
- 330
- References
- 82
- FWCI
- 5.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.